
JOIN US
Fusion Detection in Advanced NSCLC: Stay Up to Date
Targetable drivers in non-small cell lung cancer include ALK, RET, and ROS1 fusions—do you know how to detect them? DNA-based and RNA-based sequencing each have advantages and drawbacks when it comes to fusion detection. In this webinar, expert speakers will present their perspectives on fusion detection using next-generation sequencing in NSCLC.
May 22, 2024
3:30 pm ET

MARK A. SOCINSKI, MD
Internationally Recognized Expert
in Lung Cancer

KATY WONG, PhD
Director, Medical Field Team
Foundation Medicine

JENNIFER MILLS, PhD
Moderator
Vice President, Medical Affairs,
Foundation Medicine